Abate Thomas M 4
4 · Edwards Lifesciences Corp · Filed Feb 11, 2013
Insider Transaction Report
Form 4
Abate Thomas M
CVP, CFO and Treasurer
Transactions
- Exercise/Conversion
Common Stock
2013-02-07$21.95/sh+10,000$219,550→ 56,474 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2013-02-07−1,826→ 0 totalExercise: $13.81From: 2004-04-04Exp: 2013-04-03→ Common Stock (1,826 underlying) - Sale
Common Stock
2013-02-07$86.00/sh−4,506$387,516→ 52,594 total - Sale
Common Stock
2013-02-07$86.64/sh−1,200$103,968→ 57,100 total - Sale
Common Stock
2013-02-07$85.13/sh−6,120$520,996→ 46,474 total - Exercise/Conversion
Common Stock
2013-02-07$13.81/sh+1,826$25,217→ 58,300 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2013-02-07−10,000→ 37,000 totalExercise: $21.95From: 2007-05-11Exp: 2013-05-10→ Common Stock (10,000 underlying)
Footnotes (5)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 28, 2012.
- [F2]This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
- [F3]This transaction was executed in multiple trades at prices ranging from $86.59 to $86.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $85.58 to $86.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $84.55 to $85.53. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.